LIVESPO A FUTURE WITHOUT ANTIBIOTICS
LIVE

Add to watchlist:

No watchlists yet
View on USPTO

LIVESPO A FUTURE WITHOUT ANTIBIOTICS Trademark

Serial Number: 79392436 • Registration: 7781183

LIVESPO A FUTURE WITHOUT ANTIBIOTICS is a trademark filed by LIVESPO GLOBAL JOINT STOCK COMPANY on November 30, 2023. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

LIVESPO GLOBAL JOINT STOCK COMPANY

A1, No 4 Dinh Cong new urban area,

Entity Type: 99

Trademark Details

Filing Date

November 30, 2023

Registration Date

May 6, 2025

Published for Opposition

March 18, 2025

Goods & Services

Pharmaceuticals, namely, pharmaceutical preparations for supportive treatment and prevention of intestinal diseases, including dysbiosis in the nature of imbalanced microbiota, inflammatory bowel disease (IBD), irritable bowel syndrome (IBS), diarrhea, constipation, anorexia, and underweight; Pharmaceuticals, namely, pharmaceutical preparations for supportive treatment and prevention of respiratory diseases, runny nose, nasal congestion, allergic rhinitis, cough, and respiratory infections caused by RSV and influenza virus; Pharmaceuticals, namely, pharmaceutical preparations for supportive treatment and prevention of dental diseases, including tooth decay and periodontitis; Pharmaceuticals, namely, pharmaceutical preparations for supportive treatment and prevention of vaginal disorders, such as itching, irritation, unpleasant odor, abnormal discharge, and discoloration of vaginal secretions; Pharmaceuticals, namely, pharmaceutical preparations for supportive treatment and prevention of skin diseases, including mild to moderate acne, oily skin, and atopic dermatitis; Dietetic foods adapted for medical use; Bio-products for medical purposes, namely, biological preparations for the treatment of supportive treatment and prevention of intestinal diseases, including dysbiosis in the nature of imbalanced microbiota, inflammatory bowel disease (IBD), irritable bowel syndrome (IBS), diarrhea, constipation, anorexia, and underweight; Bio-products for medical purposes, namely, biological preparations for the treatment of supportive treatment and prevention of respiratory diseases, runny nose, nasal congestion, allergic rhinitis, cough, and respiratory infections caused by RSV and influenza virus; Bio-products for medical purposes, namely, biological preparations for the treatment of supportive treatment and prevention of dental diseases, including tooth decay and periodontitis; Bio-products for medical purposes, namely, biological preparations for the treatment of supportive treatment and prevention of vaginal disorders, such as itching, irritation, unpleasant odor, abnormal discharge, and discoloration of vaginal secretions; Bio-products for medical purposes, namely, biological preparations for the treatment of supportive treatment and prevention of skin diseases, including mild to moderate acne, oily skin, and atopic dermatitis

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Feb 19, 2026 FINO
GENERIC MADRID TRANSACTION SENT TO IB
Dec 2, 2025 XXSS
GENERIC MADRID TRANSACTION CREATED
Dec 1, 2025 XXCR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Sep 12, 2025 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Aug 27, 2025 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Aug 27, 2025 OPNR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Aug 6, 2025 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
May 6, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
May 6, 2025 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 18, 2025 NPUB
PUBLISHED FOR OPPOSITION
Mar 18, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 12, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 21, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 21, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 20, 2025 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Feb 20, 2025 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Feb 12, 2025 GNFN
FINAL REFUSAL E-MAILED
Feb 12, 2025 GNFR
FINAL REFUSAL WRITTEN
Feb 12, 2025 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 23, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 23, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 23, 2025 TROA
REFUSAL PROCESSED BY IB
Aug 17, 2024 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jul 29, 2024 RFCS
REFUSAL PROCESSED BY MPU
Jul 29, 2024 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jun 29, 2024 RFCR
NON-FINAL ACTION WRITTEN
Jun 28, 2024 CNRT
ASSIGNED TO EXAMINER
Jun 27, 2024 DOCK
APPLICATION FILING RECEIPT MAILED
Apr 5, 2024 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 1, 2024 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Mar 28, 2024 REPR